B-cell Lymphoma

Showing 76 - 95 of 95

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma Trial in Beijing (PZ01 CAR-T cells)

Unknown status
  • B-cell Acute Lymphoblastic Leukemia
  • B-cell Lymphoma
  • PZ01 CAR-T cells
  • Beijing, Beijing, China
    Department of Hematology, Navy General Hospital of PLA
Sep 14, 2017

B-cell Lymphoma Trial in Worldwide (Bevacizumab, Rituximab, CHOP)

Terminated
  • B-cell Lymphoma
  • La Jolla, California
  • +265 more
Jun 26, 2017

B-cell Lymphoma, Indolent B-cell Lymphoma Trial in Boston (rituximab)

Completed
  • B-cell Lymphoma
  • Indolent B-cell Lymphoma
  • Boston, Massachusetts
  • +1 more
May 9, 2017

B-Cell Leukemia, B-Cell Lymphoma Trial in Shijiazhuang (Autologous CD19-targeting CAR T cells)

Unknown status
  • B-Cell Leukemia
  • B-Cell Lymphoma
  • Autologous CD19-targeting CAR T cells
  • Shijiazhuang, Hebei, China
    No.2 Hospital of Hebei Medical University
Apr 27, 2017

Non-Hodgkin's Lymphoma, B-cell Lymphoma Trial in Sutton (bevacizumab, Rituximab)

Terminated
  • Non-Hodgkin's Lymphoma
  • B-cell Lymphoma
  • bevacizumab, Rituximab
  • Sutton, Surrey, United Kingdom
  • +1 more
Oct 13, 2016

B-cell Lymphoma, Non-Hodgkin's Lymphoma Trial in Philadelphia (Bexxar)

Completed
  • B-cell Lymphoma
  • Non-Hodgkin's Lymphoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center, University of Pennsylvania
Aug 15, 2016

B-cell Lymphoma Trial in Lund (90Y-ibritumomab)

Completed
  • B-cell Lymphoma
  • Lund, Sweden
    Lund University Hospital
Feb 18, 2016

Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes,

Completed
  • Febrile Neutropenia
  • +8 more
    • Innsbruck, Austria
    • +119 more
    Dec 9, 2015

    B-Cell Lymphoma Trial in New Haven (Clofarabine)

    Completed
    • B-Cell Lymphoma
    • New Haven, Connecticut
      Yale Comprehensive Cancer Center at Yale University School of Me
    Jan 28, 2015

    B-cell Lymphoma, Fatigue Trial (Armodafinil, )

    Withdrawn
    • B-cell Lymphoma
    • Fatigue
    • (no location specified)
    Jul 22, 2013

    B-Cell Lymphoma, B-Cell Leukemia Trial in United States (PCI-32765)

    Completed
    • B-Cell Lymphoma
    • B-Cell Leukemia
    • Palo Alto, California
    • +8 more
    May 21, 2013

    Non-Hodgkin's Lymphoma, B-cell Lymphoma Trial in San Francisco (Velcade (bortezomib), rituximab, ifosfamide, carboplatin,

    Terminated
    • Non-Hodgkin's Lymphoma
    • B-cell Lymphoma
    • Velcade (bortezomib), rituximab, ifosfamide, carboplatin, etoposide
    • San Francisco, California
      Unviersity of California Medical Center
    Sep 24, 2012

    B-Cell Lymphoma Trial in Bethesda, Buffalo (PS-341, Etoposide, Doxorubicin)

    Completed
    • B-Cell Lymphoma
    • Bethesda, Maryland
    • +1 more
    Aug 10, 2012

    B-Cell Lymphoma Trial in New York, Villejuif, Sheffield (half cyclophosphamide, without COPADM3, mini CYVE, without 3

    Completed
    • B-Cell Lymphoma
    • half cyclophosphamide
    • +4 more
    • New York, New York
    • +2 more
    Mar 27, 2012

    B-Cell Lymphoma Trial in Nantes (Rituximab)

    Completed
    • B-Cell Lymphoma
    • Nantes, France
      University Hospital
    Aug 25, 2009

    B-Cell Lymphoma, Hodgkin's Disease Trial in Atlanta (Thalidomide)

    Terminated
    • B-Cell Lymphoma
    • Hodgkin's Disease
    • Atlanta, Georgia
      Emory University Winship Cancer Institute
    May 6, 2009

    Malignancies, B-Cell Lymphoma Trial in Boston, Houston (Aroplatin)

    Completed
    • Malignancies
    • B-Cell Lymphoma
    • Boston, Massachusetts
    • +1 more
    Oct 24, 2008

    B-Cell Lymphoma, Follicular Lymphoma, Marginal Lymphoma Trial in United States (VELCADE and rituximab)

    Completed
    • B-Cell Lymphoma
    • +2 more
    • VELCADE and rituximab
    • Los Angeles, California
    • +12 more
    Feb 7, 2008

    B-Cell Lymphoma Trial in Belgium, France, Switzerland (Zevalin plus BEAM)

    Completed
    • B-Cell Lymphoma
    • Zevalin plus BEAM
    • Mont-Godinne, Belgium
    • +8 more
    Sep 6, 2006